0 Комментарии
0 Поделились
7 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
The Autoimmune Revolution: Targeted Biologics Transform Chronic Disease ManagementThe management of Autoimmune Diseases represents a major, sustained application segment for the Biologic Therapy Market, second only to oncology in its clinical impact and commercial value. Autoimmune conditions, such as rheumatoid arthritis, psoriasis, inflammatory bowel diseases, and multiple sclerosis, are chronic, debilitating, and affect millions globally. For decades, treatment relied on...0 Комментарии 0 Поделились 299 Просмотры 0 предпросмотр
-
The Autoimmune Revolution: Targeted Biologics Transform Chronic Disease ManagementThe management of Autoimmune Diseases represents a major, sustained application segment for the Biologic Therapy Market, second only to oncology in its clinical impact and commercial value. Autoimmune conditions, such as rheumatoid arthritis, psoriasis, inflammatory bowel diseases, and multiple sclerosis, are chronic, debilitating, and affect millions globally. For decades, treatment relied on...0 Комментарии 0 Поделились 312 Просмотры 0 предпросмотр
-
Basal Insulin Market to Reach $38.36 Billion by 2032Introspective Market Research (IMR) today announced its latest market intelligence report on the Global Basal Insulin Market, projecting rapid expansion over the next decade. The study indicates that the market, valued at USD 16.4 billion in 2023, is expected to reach USD 38.36 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.9% during 2024–2032. This strong growth...0 Комментарии 0 Поделились 21 Просмотры 0 предпросмотр